Celltrion
068270.KS
#911
Rank
A$39.64 B
Marketcap
A$172.89
Share price
3.96%
Change (1 day)
-13.27%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): A$2.88

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$2.73. an increase over its 2024 EPS that were of A$1.77.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025A$4.68163.66%
2024A$1.77-53.73%
2023A$3.83-2.08%
2022A$3.91-11.72%
2021A$4.432.03%
2020A$4.3582.8%
2019A$2.3818.31%
2018A$2.01-36.33%
2017A$3.16161.25%
2016A$1.212.86%
2015A$1.1717.84%
2014A$1.005.87%
2013A$0.94-70.85%
2012A$3.23134.09%
2011A$1.3843.59%
2010A$0.9674.49%
2009A$0.55317.8%
2008A$0.13-71.7%
2007A$0.47